On December 6th, the National Medical Insurance Bureau issued the “Opinions on Supervising the Drug Price.” The “Opinion” indicated that a pricing system that depends on the market should be encouraged, and the centralised procurement with defined quantities, of which the drug price depends on the quantities and the bidding process combines with the procurement, should be further implemented. The “Opinion” also stipulated that a pre-warning system of abnormal drug price movements and an investigation system of the cost price of drugs should be established as well.
国家医保局发布文件：监管药品价格 调查成本
来源：医药网 2019.12.09
12月6日，国家医保局发布《关于做好当前药品价格管理工作的意见》（以下简称《意见》）。《意见》指出，坚持市场调节药品价格的总体方向；坚持“带量采购、量价挂钩、招采合一”的方针。《意见》要求，应建立价格供应异常变动监测预警机制，并完善药品价格成本调查工作机制。
Leave a Reply